Precision BioSciences Inc
NASDAQ:DTIL
Precision BioSciences Inc
Revenue
Precision BioSciences Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Precision BioSciences Inc
NASDAQ:DTIL
|
Revenue
$57.5m
|
CAGR 3-Years
20%
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Revenue
$54.4B
|
CAGR 3-Years
3%
|
CAGR 5-Years
11%
|
CAGR 10-Years
11%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Revenue
$27.5B
|
CAGR 3-Years
2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
7%
|
|
Amgen Inc
NASDAQ:AMGN
|
Revenue
$29.5B
|
CAGR 3-Years
5%
|
CAGR 5-Years
4%
|
CAGR 10-Years
5%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Revenue
$10.2B
|
CAGR 3-Years
17%
|
CAGR 5-Years
26%
|
CAGR 10-Years
26%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Revenue
$13.1B
|
CAGR 3-Years
13%
|
CAGR 5-Years
15%
|
CAGR 10-Years
19%
|
See Also
What is Precision BioSciences Inc's Revenue?
Revenue
57.5m
USD
Based on the financial report for Mar 31, 2024, Precision BioSciences Inc's Revenue amounts to 57.5m USD.
What is Precision BioSciences Inc's Revenue growth rate?
Revenue CAGR 5Y
31%
Over the last year, the Revenue growth was 88%. The average annual Revenue growth rates for Precision BioSciences Inc have been 20% over the past three years , 31% over the past five years .